Development and Validation of the Sinonasal Outcome Test-12

Objectives: Quality of life (QoL) questionnaires are widely used in clinical interviews to assess the impact of medical interventions or measure the outcomes of healthcare services. The main aim of such questionnaires is the subjective assessment of health status and its impact on QoL. This study ai...

Full description

Saved in:
Bibliographic Details
Published inJournal of primary care & community health Vol. 14; p. 21501319231189060
Main Authors Al Sharhan, Salma S., Al Bar, Mohammed H., Al Saied, Abdulmalik S., Al Somali, Maha I., Abdel Wahab, Moataza M.
Format Journal Article
LanguageEnglish
Published Los Angeles, CA SAGE Publications 01.01.2023
SAGE PUBLICATIONS, INC
SAGE Publishing
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Objectives: Quality of life (QoL) questionnaires are widely used in clinical interviews to assess the impact of medical interventions or measure the outcomes of healthcare services. The main aim of such questionnaires is the subjective assessment of health status and its impact on QoL. This study aimed to develop an efficient, short sinonasal disease assessment instrument, the sinonasal outcomes test-12 (SNOT-12), and to compare it with the preexisting SNOT-22. Methods: This was a two-phase cross-sectional study. The study was performed between June 2019 and February 2020 using the electronic files of the ORL department outpatient clinics at King Fahd University Hospital, affiliated with Imam Abdulrahman Bin Faisal University. The study was performed in 2 phases: an item reduction phase, which resulted in an initial SNOT-12 scale, and a validation phase, using a comparative analysis of the initial SNOT-12 and the SNOT-22. Results: The developed short-form SNOT-12 maintained the 4 latent factors extracted in EFA (nasal, Sleep/extra nasal, psychological, ear/facial). It strongly correlated with SNOT-22 (r = 0.973). It had good construct reliability (0.705-0.901) and validity and a higher discrimination power than the SNOT-22. Conclusions: The SNOT-12 is a short, valid, and reliable instrument that may prove useful for the initial screening and monitoring of patients with chronic rhinosinusitis.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:2150-1319
2150-1327
DOI:10.1177/21501319231189060